Michihiro Mutoh

Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents.

P M O'Connor, Joany Jackman, I Bae et al. · PubMed · 1997 · 882 citations

Medicine, Cancer Biology, Molecular Biology +15

Involvement of prostaglandin E receptor subtype EP(4) in colon carcinogenesis.

Michihiro Mutoh, Kouji Watanabe, Tomohiro Kitamura et al. · PubMed · 2002 · 369 citations

Medicine, Oncology, Pharmacology +10

Inhibition by berberine of cyclooxygenase-2 transcriptional activity in human colon cancer cells

Kazunori Fukuda, Yuko Hibiya, Michihiro Mutoh et al. · Journal of Ethnopharmacology · 1999 · 271 citations

Medicine, Oncology, Pharmacology +9

Suppression of cyclooxygenase-2 promoter-dependent transcriptional activity in colon cancer cells by chemopreventive agents with a resorcin-type structure

Michihiro Mutoh · Carcinogenesis · 2000 · 189 citations · Full text

Medicine, Oncology, Pharmacology +13

Altered expression of β-catenin, inducible nitric oxide synthase and cyclooxygenase-2 in azoxymethane-induced rat colon carcinogenesis

Mami Takahashi, Michihiro Mutoh, Toshihiko Kawamori et al. · Carcinogenesis · 2000 · 168 citations · Full text

Medicine, Oncology, Pathobiology +17